Topical dicloxacillin solution wash for papulopustular eruptions and purpuric drug eruptions due to epidermal growth factor inhibitors
Int J Dermatol
.
2021 Jul;60(7):e278-e281.
doi: 10.1111/ijd.15468.
Epub 2021 Mar 27.
Authors
Chun-Wei Lu
1
2
,
Chiao-En Wu
2
3
,
Ping-Chih Hsu
2
4
,
Yueh-Fu Fang
2
4
,
Shih-Hong Li
2
4
,
Li-Chuan Tseng
5
,
Feng-Ya Shih
5
Affiliations
1
Department of Dermatology, Drug Hypersensitivity Clinical and Research Center, Chang Gung Memorial Hospital, Linkou, Taiwan.
2
College of Medicine, Chang Gung University, Taoyuan, Taiwan.
3
Division of Hematology-Oncology, Department of Internal Medicine, Chang Gung Memorial Hospital, Linkou, Taiwan.
4
Division of Thoracic Medicine, Department of Internal Medicine, Chang Gung Memorial Hospital, Linkou, Taiwan.
5
Department of Oncology Case Management, Chang Gung Memorial Hospital, Linkou, Taiwan.
PMID:
33772770
DOI:
10.1111/ijd.15468
No abstract available
Publication types
Letter
MeSH terms
Antineoplastic Agents* / therapeutic use
Dicloxacillin / therapeutic use
Drug Eruptions* / drug therapy
Drug Eruptions* / etiology
Humans
Substances
Antineoplastic Agents
Dicloxacillin
Grants and funding
CMRPGBI0011-3/Chang Gung Memorial Hospital